Cargando…

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species

Tyrosine kinase inhibitors (TKI) have become a first‐line treatment for chronic myeloid leuakemia (CML). TKIs efficiently target bulk CML cells; however, they are unable to eliminate the leukaemic stem cell (LSC) population that causes resistance and relapse in CML patients. In this study, we assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flores‐Lopez, Gabriela, Moreno‐Lorenzana, Dafne, Ayala‐Sanchez, Manuel, Aviles‐Vazquez, Socrates, Torres‐Martinez, Hector, Crooks, Peter A., Guzman, Monica L., Mayani, Hector, Chávez‐González, Antonieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156390/ https://www.ncbi.nlm.nih.gov/pubmed/30079458 http://dx.doi.org/10.1111/jcmm.13755

Ejemplares similares

CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI
por: Moreno-Lorenzana, Dafne, et al.
Publicado: (2016)

Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib
por: Avilés‐Vázquez, Sócrates, et al.
Publicado: (2017)

Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
por: Carlisi, D, et al.
Publicado: (2016)

Cell Contact with Endothelial Cells Favors the In Vitro Maintenance of Human Chronic Myeloid Leukemia Stem and Progenitor Cells
por: Torres-Barrera, Patricia, et al.
Publicado: (2022)

NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT
por: Nakshatri, H, et al.
Publicado: (2015)

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)
por: Mosayebian, Ali, et al.
Publicado: (2021)

Low c-Kit expression identifies primitive, therapy-resistant CML stem cells
por: Shah, Mansi, et al.
Publicado: (2023)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
por: Zong, Hongliang, et al.
Publicado: (2015)

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells
por: LoBianco, Francesca V., et al.
Publicado: (2022)

Crystal structure of 13-(E)-(2-aminobenzylidene)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2018)

The regulation of hematopoietic stem cell populations
por: Mayani, Hector
Publicado: (2016)

Apoptotic and Cell Cycle Effects of Triterpenes Isolated from Phoradendron wattii on Leukemia Cell Lines
por: Valencia-Chan, Lía S., et al.
Publicado: (2022)

Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide
por: Tiuman, Tatiana Shioji, et al.
Publicado: (2014)

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017)

Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells
por: Shi, Chen, et al.
Publicado: (2017)

Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
por: D'Anneo, A, et al.
Publicado: (2013)

Isolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays
por: Rodríguez, Alfredo, et al.
Publicado: (2021)

Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
por: Liu, Jun-Wei, et al.
Publicado: (2010)

Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
por: Cui, Meng, et al.
Publicado: (2022)

Eradication of CML stem cells
por: Carter, Bing Z., et al.
Publicado: (2016)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
por: Liu, Yu Chuan, et al.
Publicado: (2017)

Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells in vitro
por: Kouhpaikar, Hamideh, et al.
Publicado: (2020)

Anti-Inflammatory and Antiosteoclastogenic Activities of Parthenolide on Human Periodontal Ligament Cells In Vitro
por: Zhang, Xufang, et al.
Publicado: (2014)

Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide
por: Ede, Benjamin C., et al.
Publicado: (2018)

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
por: Tian, Bo, et al.
Publicado: (2020)

Modulation of Cell Surface Protein Free Thiols: A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide
por: Skalska, Jolanta, et al.
Publicado: (2009)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023)

Parthenolide Induces Apoptosis and Cell Cycle Arrest of Human 5637 Bladder Cancer Cells In Vitro
por: Cheng, Guang, et al.
Publicado: (2011)

Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022)

Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells
por: Huang, Le-Tian, et al.
Publicado: (2023)

Sangre blanca : Doscientos años de estudio y tratamiento de la leucemia.
por: Mayani, Héctor 1960-
Publicado: (2016)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2020)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
por: Carlisi, Daniela, et al.
Publicado: (2022)

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4aqb704j7netujrraqh8rrgors